← Leaderboards
Edikan Ogunnaike
Univ Of North Carolina Chapel Hill
$480,005
Attributed
$480,005
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$480,005 · 2
By mechanism
R00$248,999 · 1
K99$231,006 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Henry Shelton Earp$37,241,767
- Kurt M. Ribisl$35,707,733
- Terry R Magnuson$26,376,223
- Stephanie Brooke Wheeler$7,793,710
- Matthew I Milowsky$1,917,608
Others in their field
Other Rising Stars on “Career Transition Award”
- Michael S Mazzola · Louisiana State University$6,764,332
- Jenna Mueller · North Dakota State University Fargo$5,463,690
- William D Aderholdt · North Dakota State University Fargo$4,915,814
- Brian Carroll · North Dakota State University Fargo$4,915,814
- Hollie J Mackey · North Dakota State University Fargo$4,915,814
- Vanessa Xanthakis · Boston University Medical Campus$2,778,431
Research focus
Career Transition AwardCar T Cell TherapyAgonistAffectAngiogenesisAdverse EffectsAngiogenesis InhibitorsAnimal ModelAllogenicAntitumor EffectAreaAutologousAvastinAffinityBehaviorBiocompatible MaterialsBiologicalBlood - Brain Barrier AnatomyAnimalsBrainBypassCareerCareer DevelopmentCell Mediated Immune Response
Grant awards (3)
Fibrin-CAR-T cells therapies to enhance efficacy in glioblastoma treatments$248,999
R00 · FY2025 · NS · contact PI
Fibrin-CAR-T cells therapies to enhance efficacy in glioblastoma treatments$115,503
K99 · FY2023 · NS · contact PI
Fibrin-CAR-T cells therapies to enhance efficacy in glioblastoma treatments$115,503
K99 · FY2022 · NS · contact PI